New Photobiomodulation Protocol Prevents Oral Mucositis in Hematopoietic Stem Cell Transplantation Recipients-a Retrospective Study

Overview

Journal Lasers Med Sci

Publisher Springer

Date 2017 Aug 26

PMID 28840382

Citations 13

Authors

Camila Weissheimer

Marina Curra

Lauro J Gregianin

Liane E Daudt

Vivian P Wagner

Marco Antonio T Martins

Manoela D Martins

Affiliations

Soon will be listed here.

Abstract

Oral mucositis (OM) is an adverse side effect among hematopoietic stem cell transplantation (HSCT) recipients. The objective of this retrospective study was to evaluate the preventive effect of photobiomodulation (PBM) applied three times per week versus seven times per week in patients undergoing HSCT. The risk factors related to the incidence and severity of OM were also assessed. This was a retrospective study that evaluated 99 HSCT recipients who received different PBM protocols. Group I received three sessions per week, and group II received daily treatment. PBM was applied using a continuous-wave diode laser (InGaAlP; MM Optics, São Carlos, SP, Brazil) at a wavelength of 660 nm (visible-red) and a total radiant energy of 0.24 J per point. The baseline disease, type of transplant, type of conditioning, prophylaxis against graft-versus-host disease, OM grade, absolute leukocyte and platelet counts, and levels of liver and renal function markers were collected from medical records. The patients' age ranged from 13 to 71 years (mean/SD, 40.54 ± 16.45). No significant difference was observed between groups I and II regarding sex, age, ethnic, diagnosis, donor type, and conditioning treatment. Both PBM protocols were equally efficient in preventing OM (p = 0.34, ANOVA). Independent of the PBM protocol used, patients who received allogeneic transplant (p < 0.01-Fischer's exact test), total body irradiation (TBI-12Gy) (p = 0.01-chi-square test), busulfan + cyclophosphamide (p < 0.01-chi-square test), or methotrexate-containing regimens (p < 0.01-Fischer's exact test) demonstrated higher OM incidence and severity. Myelosuppression (p < 0.01-Mann-Whitney test) and impaired renal function (p = 0.02-Mann-Whitney test) were also considered risk factors for OM. Based on this retrospective data, PBM was effective in preventing OM in patients undergoing HSCT even when it was applied three times a week. A prospective study might be necessary to confirm these findings.

Citing Articles

Photobiomodulation for the prevention and treatment of oral mucositis in patients submitted to hematopoietic stem cell transplantation: health quality evaluation.

Marinho L, Freire G, Silva D, de Lima K, da Silveira E, Potter G Support Care Cancer. 2024; 32(11):760.

PMID: 39480546 DOI: 10.1007/s00520-024-08952-y.

Proposal of a prophylactic photobiomodulation protocol for chemotherapy-induced oral and oropharyngeal mucositis: a randomized clinical trial.

Heimlich F, de Arruda J, Pereira N, Faria L, Abreu L, Ferreira M Lasers Med Sci. 2023; 38(1):245.

PMID: 37889325 DOI: 10.1007/s10103-023-03916-w.

Photobiomodulation and vitamin B treatment alleviate both thermal and mechanical orofacial pain in rats.

Marques D, Chacur M, Martins D Photochem Photobiol Sci. 2023; 22(10):2315-2327.

PMID: 37340216 DOI: 10.1007/s43630-023-00452-y.

Exercise Improves Orofacial Pain and Modifies Neuropeptide Expression in a Rat Model of Parkinson's Disease.

Binda K, Chacur M, Martins D Neurotox Res. 2023; 41(5):459-470.

PMID: 37266893 DOI: 10.1007/s12640-023-00651-6.

The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option.

Gomes J, Wanzeler A, Junior S, Chaves Soares R, de Oliveira C, Rodrigues E Oncotarget. 2023; 14:23-39.

PMID: 36634224 PMC: 9836383. DOI: 10.18632/oncotarget.28338.

References

Lopez T, Martins M, Pavesi V, Ferreira L, Bussadori S, Moreira M . Effect of laser phototherapy in the prevention and treatment of chemo-induced mucositis in hamsters. Braz Oral Res. 2013; 27(4):342-8. DOI: 10.1590/S1806-83242013005000019. View

Legert K, Remberger M, Ringden O, Heimdahl A, Dahllof G . Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients. Support Care Cancer. 2014; 22(8):2133-40. DOI: 10.1007/s00520-014-2190-7. View

Lalla R, Bowen J, Barasch A, Elting L, Epstein J, Keefe D . MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014; 120(10):1453-61. PMC: 4164022. DOI: 10.1002/cncr.28592. View

Rubenstein E, Peterson D, Schubert M, Keefe D, McGuire D, Epstein J . Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004; 100(9 Suppl):2026-46. DOI: 10.1002/cncr.20163. View

Chor A, Torres S, Maiolino A, Nucci M . Low-power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation. Eur J Haematol. 2009; 84(2):178-9. DOI: 10.1111/j.1600-0609.2009.01336.x. View

Bezinelli L, Eduardo F, Marques da Graca Lopes R, Biazevic M, Eduardo C, Correa L . Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation. Hematol Oncol. 2013; 32(1):31-9. DOI: 10.1002/hon.2050. View

Wagner V, Meurer L, Martins M, Danilevicz C, Magnusson A, Marques M . Influence of different energy densities of laser phototherapy on oral wound healing. J Biomed Opt. 2013; 18(12):128002. PMC: 4019369. DOI: 10.1117/1.JBO.18.12.128002. View

Migliorati C, Hewson I, Lalla R, Spindola Antunes H, Estilo C, Hodgson B . Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer. 2012; 21(1):333-41. DOI: 10.1007/s00520-012-1605-6. View

Borzabadi-Farahani A . Effect of low-level laser irradiation on proliferation of human dental mesenchymal stem cells; a systemic review. J Photochem Photobiol B. 2016; 162:577-582. DOI: 10.1016/j.jphotobiol.2016.07.022. View

10.

Chaudhry H, Bruce A, Wolf R, Litzow M, Hogan W, Patnaik M . The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review. Biol Blood Marrow Transplant. 2015; 22(4):605-616. DOI: 10.1016/j.bbmt.2015.09.014. View

11.

Dillenburg C, Martins M, Munerato M, Marques M, Carrard V, Filho M . Efficacy of laser phototherapy in comparison to topical clobetasol for the treatment of oral lichen planus: a randomized controlled trial. J Biomed Opt. 2014; 19(6):068002. DOI: 10.1117/1.JBO.19.6.068002. View

12.

Pereira A, Eduardo C, Matson E, Marques M . Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med. 2002; 31(4):263-7. DOI: 10.1002/lsm.10107. View

13.

Schubert M, Eduardo F, Guthrie K, Franquin J, Bensadoun R, Migliorati C . A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer. 2007; 15(10):1145-54. DOI: 10.1007/s00520-007-0238-7. View

14.

Carlson K . Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival. Bone Marrow Transplant. 2005; 35(10):985-90. DOI: 10.1038/sj.bmt.1704948. View

15.

Blijlevens N, Schwenkglenks M, Bacon P, DAddio A, Einsele H, Maertens J . Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol. 2008; 26(9):1519-25. DOI: 10.1200/JCO.2007.13.6028. View

16.

Keefe D, Schubert M, Elting L, Sonis S, Epstein J, Raber-Durlacher J . Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007; 109(5):820-31. DOI: 10.1002/cncr.22484. View

17.

Ferreira B, da Motta Silveira F, de Orange F . Low-level laser therapy prevents severe oral mucositis in patients submitted to hematopoietic stem cell transplantation: a randomized clinical trial. Support Care Cancer. 2015; 24(3):1035-42. DOI: 10.1007/s00520-015-2881-8. View

18.

Marques M, Diniz I, de Cara S, Pedroni A, Abe G, DAlmeida-Couto R . Photobiomodulation of Dental Derived Mesenchymal Stem Cells: A Systematic Review. Photomed Laser Surg. 2016; 34(11):500-508. DOI: 10.1089/pho.2015.4038. View

19.

Curra M, Pellicioli A, Kretzmann Filho N, Ochs G, Matte U, Filho M . Photobiomodulation reduces oral mucositis by modulating NF-kB. J Biomed Opt. 2016; 20(12):125008. DOI: 10.1117/1.JBO.20.12.125008. View

20.

Bolwell B, Kalaycio M, Sobecks R, Andresen S, Kuczkowski E, Bernhard L . A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplant. 2002; 30(9):587-91. DOI: 10.1038/sj.bmt.1703694. View